Skip to Content
Skip to Content

Registry of CLH intentions until outcome

Registry of CLH intentions until outcome

The registry of classification and labelling (CLH) intentions until outcome lists the intentions and proposals received by ECHA for a new or revised harmonised classification and labelling of a substance. The proposals are submitted by Member State competent authorities, manufacturers, importers or downstream users.  

Interested parties can follow the progress of a proposal through the CLH process, from the notification of the intention to the adoption of the opinion of the Committee for Risk Assessment (RAC). The advance notice enables interested parties to plan and prepare for commenting later on.

Anyone with relevant information on the identity or hazard properties of a substance is encouraged to provide this information to the dossier submitter during the early stages of the process, or at the latest during the consultation.

Where an opinion has been adopted by RAC, the status is indicated as ‘Opinion Adopted’.

Note: The classification tables for those substances that have been reviewed are listed in the ‘Corrigenda to the RAC opinions’ document.

(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate; fosthiazate (ISO)

EC / List no: 619-377-3 CAS no: 98886-44-3
CLP Annex VI Index number
015-168-00-0
Further substance information
Status
Withdrawn
Date of intention
Expected date of submission
Submitted for accordance check
18/09/2020
Final submission date
Withdrawal date
03/05/2021
Legal deadline for opinion adoption
Submitter
Germany
Submitter's email
Chemg@baua.bund.de
Harmonised classification at the time of the proposal
Acute Tox. 3*, H301
Acute Tox. 4*, H312
Acute Tox. 3*, H331
Skin Sens. 1, H317
Aquatic Acute 1, H400
Aquatic Chronic 1, H410
Specific concentration limits at the time of the proposal
Proposed harmonised classification by the dossier submitter
Acute Tox. 3, H301
Acute Tox. 3, H311
Acute Tox. 3, H331
Eye Irrit. 2, H319
Skin Sens. 1, H317
Repr. 2, H361fd
Lact., H362
STOT SE 1, H370
STOT RE 2, H373
Aquatic Acute 1, H400
Aquatic Chronic 1, H410
Proposed specific concentration limits by the dossier submitter
Oral: ATE = 57 mg/kg bw
Dermal: ATE = 861 mg/kg bw
Inhalation: ATE = 0.53 mg/L (dusts or mists)
Regulatory programme
Remarks
The classification proposal will be submitted again as part or excerpt of the combined template, when the RAR has been finalised.
Start of consultation
Deadline for commenting
Hazard classes open for commenting
CLH report
Annexes to the CLH report
Date of opinion
RAC Opinion
Background document
RCOM (Comments received)
Attachments received during public consultation (excluding journal articles)
Minority opinion(s)
Other annexes
ATP number and date
Link to ATP
Latest update
12/05/2021

Categories Display

Märgistatud:

(sisu otsimiseks klõpsake sildil)


Route: .live1